Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics

References

• Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954–1956
   PubMed Web of Science ®Google Scholar
• Smith L, Luna G, Merg AR. Laparoscopic splenectomy for treatment of splenomegaly. Am J Surg 2004; 187: 618–620
   PubMed Web of Science ®Google Scholar
• Bishop JF. Adult acute myeloid leukemia: Update on treatment. Med J Aust 1999; 170: 39–43
   PubMed Web of Science ®Google Scholar
• Voakes JB, Jones SE, McKelvey EM. The chemotherapy of lymphoblastic lymphoma. Blood 1981; 57: 186–188
   PubMed Web of Science ®Google Scholar
• Liang R, Todd D, Chan TK. Intensive chemotherapy for adult lymphoblastic lymphomas. Cancer Chemother Pharmacol 1991; 29: 80–82
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN. Anthracyclines in the treatment of cancer: An overview. Drugs 1997; 54: 1–7
   PubMed Web of Science ®Google Scholar
• List AF. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 1996; 10: 937–942
   PubMed Web of Science ®Google Scholar
• Meade JB, Karp JE, Guo C, Adoo CBS, Rapoport AP. Timed sequential therapy of acute myelogenous leukemia in adults: A phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide. Leukemia Research 2003; 27: 313–321
   PubMed Web of Science ®Google Scholar
• Bauchez AS, Lunardi J, Pernin C, Marti-Battle D, Fagret D. Detection of chemoresistance profile of cell lines K562, KB, GLC4, and HL60 through characterisation of the hmdr1, mrp, and Irp transcripts. In Vivo 2001; 15: 101–104
   PubMed Web of Science ®Google Scholar
• Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaub E, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999; 94: 1192–1200
   PubMed Web of Science ®Google Scholar
• Douer D, Koeffler HP. Retinoic acid enhances colony stimulating factor induced clonal growth of normal myeloid progenitor cells in vitro. Exp Cell Res 1982; 138: 193–198
   PubMed Web of Science ®Google Scholar
• Cassinat B, Chevret S, Zassadowski F, Balitrand N, Guillemot I, Menot ML, et al. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: A novel indicator of poor patient outcome. Blood 2001; 98: 2862–2864
   PubMed Web of Science ®Google Scholar
• Sanz MA, Martin G, Cocco FL. Choice of chemotherapy in induction, consolidation and maintenance in acute prommyelocytic leukemia. Best Prac Res Clin Haematol 2003; 16: 433–451
   PubMed Web of Science ®Google Scholar
• Camitta B, Leventhal B, Lauer S, Shuster JJ, Adair S, Casper J, et al. Intermediate dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: A paediatric oncology group study. J Clin Oncol 1989; 7: 1539–1544
   PubMed Web of Science ®Google Scholar
• Koh LP, Goh YT, Teoh G, Tan P. Treatment of acute promyelocytic leukemia using a combination of all-trans retinoic acid and chemotherapy. Ann Acad Med Singapore 2001; 30: 401–408
   PubMed Web of Science ®Google Scholar
• Orive G, Hernandez RM, Gascon AR, Pedraz JL. Micro and nano drug delivery systems in cancer therapy. Cancer Ther 2005; 3: 131–138
   Google Scholar
• Bosman AW, Janssen HM, Meijer EW. About dendrimers: Structure, physical properties, and applications. Chem Rev 1999; 99: 1665–1688
   PubMed Web of Science ®Google Scholar
• Yiyun C, Tongwen X. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur J Med Chem 2005; 40: 1188–1192
   PubMed Web of Science ®Google Scholar
• Beezer AE, King ASH, Martin IK, Mitchel JC, Twyman LJ, Wain CF, et al. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron 2003; 59: 3873–3880
   Web of Science ®Google Scholar
• DeLong R, Stephenson K, Loftus T, Fisher M, Alahari S, Nolting A, et al. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery. J Pharmacol Sci 1997; 86: 762–764
   PubMed Web of Science ®Google Scholar
• Wiener EC, Konda S, Shadron A, Brechbiel M, Gan-sow O. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest Radiol 1997; 32: 748–754
   PubMed Web of Science ®Google Scholar
• Landers JJ, Cao ZY, Lee I, Piehler LT, Myc PP, Myc A, et al. Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers. J Infect Dis 2002; 186: 1222–1230
   PubMed Web of Science ®Google Scholar
• Milhem OM, Myles C, McKeown NB, Attwood D, D'Emanuele A, et al. Polyamidoamine starburst dendrimers as solubility enhancers. Int J Pharm 2000; 197: 239–241
   PubMed Web of Science ®Google Scholar
• Devarakonda B, Hill RA, De Villiers MM. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm 2004; 284: 133–140
   PubMed Web of Science ®Google Scholar
• Boas U, Heegaard PMH. Dendrimers in drug research. Chem Soc Rev 2004; 33: 43–63
   PubMed Web of Science ®Google Scholar
• Gupta U, Agashe HB, Asthana A, Jain NK. Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 2006; 7: 649–648
   PubMed Web of Science ®Google Scholar
• Morgan MT, Carnahan MA, Imoos CE, Ribeiro AA, Finkelstein S, Lee SJ, et al. Dendritic molecular capsules for hydrophobic compounds. Am Chem Soc 2003; 17: 15485–15489
   Web of Science ®Google Scholar
• Chen W, Tomalia DA, Thomas JL. Unusual pH-dependent polarity changes in PAMAM dendrimers: Evidence for pH-responsive conformational changes. Macromolecules 2000; 33: 9169–9172
   Web of Science ®Google Scholar
• Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm 2003; 257: 111–124
   PubMed Web of Science ®Google Scholar
• Bhadra D, Bhadra S, Jain NK. PEGylated peptide-based dendritic nanoparticle systems for delivery of artemther. J Drug Deliv Sci Technol 2005a; 15: 65–73
   Web of Science ®Google Scholar
• Bhadra D, Bhadra S, Jain P, Jain NK. Pegnology: A review of PEG-ylated systems. Pharmazie 2002; 57: 5–29
   PubMed Web of Science ®Google Scholar
• Chauhan AS, Sridevi S, Chalasani KB. Dendrimer-mediated transdermal delivery: Enhanced bioavailability of indomethacin. J Cont Rel 2003; 90: 335–343
   PubMed Web of Science ®Google Scholar
• Khopade AJ, Caruso F, Tripathi P, Nagaich S, Jain NK. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int J Pharm 2002; 232: 157–162
   PubMed Web of Science ®Google Scholar
• Asthana A, Chauhan AS, Diwan PV, Jain NK. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient. AAPS Pharm Sci Tech 2005; 6: E536–E542
   PubMed Web of Science ®Google Scholar
• Dutta T, Aghase HB, Vijayarajkumar P, Joshi M, Jain NK. Dendrosome-based gene delivery. J Exp Nanosci 2006; 1: 235–248
   Web of Science ®Google Scholar
• Bhadra D, Yadav AK, Bhadra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 2005b; 295: 221–233
   PubMed Web of Science ®Google Scholar
• Vijayaraj kumar P, Asthana A, Dutta T, Jain NK. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Targeting 2006; 14: 546–556
   PubMed Web of Science ®Google Scholar
• Tomalia DA, Naylor AM, Goddard WA. Starburst, dendrimers, molecular level size, shape, surface, chemistry, topology and flexibility from atoms to macroscopic matter. Angew Chem 1990; 29: 138–175
   Web of Science ®Google Scholar
• Dutta T, Jain NK. Targeting potential and anti HIV activity of mannosylated fifth generation poly(propyleneimine dendrimers. Biochim Biophys Acta 2007; 1770: 681–686
   PubMed Web of Science ®Google Scholar
• Dutta T, Agashe HB, Garg M, Balakrishnan P, Kabra M, Jain NK, et al. Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J Drug Targeting 2007; 15: 84–96
   Web of Science ®Google Scholar
• Dutta T, Garg M, Jain NK. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. Eur J Pharm Sci 2008b; 34: 181–189
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Cont Rel 2007; 123: 148–154
   PubMed Web of Science ®Google Scholar
• Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, et al. Dendrimers: Relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Cont Rel 2000; 65: 133–148
   PubMed Web of Science ®Google Scholar
• Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 2002; 19: 1310–1316
   PubMed Web of Science ®Google Scholar
• Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 2005; 57: 2215–2337
   PubMed Web of Science ®Google Scholar
• Dutta T, Garg M, Dubey V, Mishra D, Singh K, Pandita D, et al. Toxicological Investigation of surface engineered fifth generation poly(propyleneimine) dendrimers in vivo. Nanotoxicology 2008a; 2: 62–70
   Web of Science ®Google Scholar
• Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003; 24: 1121
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2001; 60: 4440–4445
   Web of Science ®Google Scholar
• Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 1994; 73: 2432–2443
   PubMed Web of Science ®Google Scholar